[
    [
        {
            "time": "2018-09-20",
            "original_text": "医药行业：带量采购祸福相依 危机并存 【中投早知道】2018-09-20 “大医保”动态跟踪系列报告之三:带量采购,祸福相依,危机并存",
            "features": {
                "keywords": [
                    "医药行业",
                    "带量采购",
                    "祸福相依",
                    "危机并存",
                    "大医保"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业：带量采购祸福相依 危机并存 【中投早知道】2018-09-20 “大医保”动态跟踪系列报告之三:带量采购,祸福相依,危机并存",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        }
    ]
]